Your browser doesn't support javascript.
loading
Capecitabine versus 5-fluorouracil in neoadjuvant chemoradiotherapy of locally advanced rectal cancer: A meta-analysis.
Zhu, Jinfeng; Zeng, Wei; Ge, Lei; Yang, Xinhui; Wang, Qisan; Wang, Haijiang.
Affiliation
  • Zhu J; Department of Gastrointestinal Surgery, The Affiliated Cancer Hospital of Xinjiang Medical University, Urumqi, Xinjiang.
  • Zeng W; Department of Hematology and Oncology, Shenzhen University General Hospital, Shenzhen, Guangdong.
  • Ge L; Shenzhen University International Cancer Center, Shenzhen, Guangdong, China.
  • Yang X; Department of Gastrointestinal Surgery, The Affiliated Cancer Hospital of Xinjiang Medical University, Urumqi, Xinjiang.
  • Wang Q; Department of Gastrointestinal Surgery, The Affiliated Cancer Hospital of Xinjiang Medical University, Urumqi, Xinjiang.
  • Wang H; Department of Gastrointestinal Surgery, The Affiliated Cancer Hospital of Xinjiang Medical University, Urumqi, Xinjiang.
Medicine (Baltimore) ; 98(17): e15241, 2019 Apr.
Article in En | MEDLINE | ID: mdl-31027072

Full text: 1 Database: MEDLINE Main subject: Rectal Neoplasms / Chemoradiotherapy, Adjuvant / Capecitabine / Fluorouracil Type of study: Etiology_studies / Systematic_reviews Language: En Journal: Medicine (Baltimore) Year: 2019 Type: Article

Full text: 1 Database: MEDLINE Main subject: Rectal Neoplasms / Chemoradiotherapy, Adjuvant / Capecitabine / Fluorouracil Type of study: Etiology_studies / Systematic_reviews Language: En Journal: Medicine (Baltimore) Year: 2019 Type: Article